Nitazoxanide protects cats from feline calicivirus infection and acts synergistically with mizoribine in vitro
Authors:
- 1 October 2020
- journal article
- research article
- Published by Elsevier in Antiviral Research
- Vol. 182, 104827
Abstract
No abstract availableKeywords
Funding Information
- Ministry of Science and Technology of China
- National Key R&D Program (2016YFD0501002)
This publication has 26 references indexed in Scilit:
- In Vitro Antiviral Activity of Clove and Ginger Aqueous Extracts against Feline Calicivirus, a Surrogate for Human NorovirusJournal of Food Protection, 2016
- In vitro antiviral effect of germacrone on feline calicivirusArchives of Virology, 2016
- Searching for Drug Synergy in Complex Dose–Response Landscapes Using an Interaction Potency ModelComputational and Structural Biotechnology Journal, 2015
- Two outbreaks of virulent systemic feline calicivirus infection in cats in Germany.2011
- Norovirus gastroenteritis successfully treated with nitazoxanideJournal of Infection, 2011
- Dealing with a potential case of FCV‐associated virulent systemic diseaseVeterinary Record, 2011
- Distribution of the Feline Calicivirus Receptor Junctional Adhesion Molecule A in Feline TissuesVeterinary Pathology, 2010
- Inhibitory effect of mizoribine and ribavirin on the replication of severe acute respiratory syndrome (SARS)-associated coronavirusAntiviral Research, 2005
- Inhibitors of the IMPDH Enzyme as Potential Anti-Bovine Viral Diarrhoea Virus AgentsAntiviral Chemistry and Chemotherapy, 2002
- Recent progress in antiviral chemotherapy for respiratory syncytial virus infectionsExpert Opinion on Investigational Drugs, 2000